Breast cancer is one of the most prevalent tumor types, largely affecting women, but also a small number of men. Although the disease is relatively well understood in comparison to other tumor types, significant unmet needs exist.

Our multi functional nanobindi based products  use core shell architecture to deliver the chemotherapy. It does not contain chemical solvents, like Cremophor. This eliminates the need for premedication with steroids or antihistamines for hypersensitivity reactions caused by these solvents. Plus, since our products can be administered in just 5 minutes or less (compared to 3 hours for solvent-based paclitaxel), it is very patient friendly.